Texas Medical Center, a medical complex that includes multiple universities located in the US state, has launched a $25m fund to invest in early-stage healthcare technologies in Houston.
Texas Medical Center (TMC), a medical complex based in the US state of Texas whose members include several local universities, has launched a $25m venture fund aimed at the Houston ecosystem.
The TMC Venture Fund will invest in technologies and early-stage companies in the healthcare sector, focusing on businesses linked to either the centre or the Houston ecosystem.
TMC’s 46 member institutions include Baylor College of Medicine, Texas A&M University’s Health Science Center, Rice University, Houston University and University of Texas’ UTHealth, MD Anderson Cancer Center and Medical Branch Health.
Other members include Houston Baptist University, Houston Academy of Medicine, Pairie View A&M University, Texas Southern University, Texas Woman’s University and University of St Thomas Houston.
The fund has already committed investments to five companies:
- Alleviant Medical, which is working on relieving heart failure symptoms.
- Briteseed, which is commercialising smart surgical tools that feature cautery, dissection and optical tissue sensing to make surgery safer.
- CNSDose, which relies on genetic technology to quickly identify the best antidepressant and dose for a patient.
- Medable, which has developed a platform for clinical care and clinical trials, collecting patient-generated data to enable better research and allow for personalised and predictive medicine.
- Noninvasix, which hopes to tackle neonatal mortality and morbidity by using a patient monitor that non-invasively measures brain oxygenation in premature babies.
